Cargando…
Gandouling Tablets Inhibit Excessive Mitophagy in Toxic Milk (TX) Model Mouse of Wilson Disease via Pink1/Parkin Pathway
OBJECTIVE: Gandouling (GDL) tablet is a Chinese patent medicine approved by the National Medical Product Administration, which is used to treat Wilson disease (WD) in China. In this study, we aimed to investigate the effects of GDL on mitophagy in the hippocampus in the toxic milk (TX) mouse model o...
Autores principales: | Zhang, Jing, Tang, Lu-Lu, Li, Liang-Yong, Cui, Shen-Wei, Jin, Shan, Chen, Huai-Zhen, Yang, Wen-Ming, Xie, Dao-Jun, Yu, Gu-Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787754/ https://www.ncbi.nlm.nih.gov/pubmed/33456485 http://dx.doi.org/10.1155/2020/3183714 |
Ejemplares similares
-
Mitophagy and Parkinson's disease: The PINK1–parkin link()
por: Deas, Emma, et al.
Publicado: (2011) -
Loss of iron triggers PINK1/Parkin-independent mitophagy
por: Allen, George F G, et al.
Publicado: (2013) -
Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria
por: Xiao, Bin, et al.
Publicado: (2017) -
Integrated Metabolomics and Network Pharmacology to Reveal the Mechanisms of Gandouling Tablets Against Copper-Overload-Induced Neuronal Injury in Rats with Wilson’s Disease
por: Chen, Li, et al.
Publicado: (2023) -
GanDouLing promotes proliferation and differentiation of neural stem cells in the mouse model of Wilson’s disease
por: Dong, Ting, et al.
Publicado: (2021)